Literature DB >> 21565984

Does physical inactivity cause nonalcoholic fatty liver disease?

R Scott Rector1, John P Thyfault.   

Abstract

While physical activity represents a key element in the prevention and management of many chronic diseases, we and others believe that physical inactivity is a primary cause of obesity and associated metabolic disorders. Unfortunately, accumulating evidence suggests that we have engineered physical activity out of our normal daily living activity. One such consequence of our sedentary and excessive lifestyle is nonalcoholic fatty liver disease (NAFLD), which is now considered the most common cause of chronic liver disease in Westernized societies. In this review, we will present evidence that physical inactivity, low aerobic fitness, and overnutrition, either separately or in combination, are an underlying cause of NAFLD.

Entities:  

Mesh:

Year:  2011        PMID: 21565984     DOI: 10.1152/japplphysiol.00384.2011

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  37 in total

1.  Intrinsic (Genetic) Aerobic Fitness Impacts Susceptibility for Metabolic Disease.

Authors:  John P Thyfault; E Matthew Morris
Journal:  Exerc Sport Sci Rev       Date:  2017-01       Impact factor: 6.230

Review 2.  Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

Authors:  Emilio Molina-Molina; Raquel Lunardi Baccetto; David Q-H Wang; Ornella de Bari; Marcin Krawczyk; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2018-06-14       Impact factor: 4.686

3.  Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.

Authors:  Melissa A Linden; Ryan D Sheldon; Grace M Meers; Laura C Ortinau; E Matthew Morris; Frank W Booth; Jill A Kanaley; Victoria J Vieira-Potter; James R Sowers; Jamal A Ibdah; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

4.  Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training.

Authors:  Melissa A Linden; Justin A Fletcher; E Matthew Morris; Grace M Meers; M Harold Laughlin; Frank W Booth; James R Sowers; Jamal A Ibdah; John P Thyfault; R Scott Rector
Journal:  Med Sci Sports Exerc       Date:  2015-03       Impact factor: 5.411

Review 5.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

6.  Sex differences in the regulation of hepatic mitochondrial turnover following physical activity: do males need more quality control than females?

Authors:  Catherine A Bellissimo; Christopher G R Perry
Journal:  J Physiol       Date:  2018-10-28       Impact factor: 5.182

7.  Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.

Authors:  Melissa A Linden; Justin A Fletcher; E Matthew Morris; Grace M Meers; Monica L Kearney; Jacqueline M Crissey; M Harold Laughlin; Frank W Booth; James R Sowers; Jamal A Ibdah; John P Thyfault; R Scott Rector
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

8.  A return to ad libitum feeding following caloric restriction promotes hepatic steatosis in hyperphagic OLETF rats.

Authors:  Melissa A Linden; Justin A Fletcher; Grace M Meers; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-21       Impact factor: 4.052

9.  Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats.

Authors:  Ryan D Sheldon; M Harold Laughlin; R Scott Rector
Journal:  J Appl Physiol (1985)       Date:  2014-02-27

10.  Intrinsic aerobic capacity impacts susceptibility to acute high-fat diet-induced hepatic steatosis.

Authors:  E Matthew Morris; Matthew R Jackman; Ginger C Johnson; Tzu-Wen Liu; Jordan L Lopez; Monica L Kearney; Justin A Fletcher; Grace M E Meers; Lauren G Koch; Stephen L Britton; R Scott Rector; Jamal A Ibdah; Paul S MacLean; John P Thyfault
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-24       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.